Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

STATs profiling reveals predominantly‐activated STAT3 in cholangiocarcinoma genesis and progression
Hasaya Dokduang, Anchalee Techasen, Nisana Namwat, et al.
Journal of Hepato-Biliary-Pancreatic Sciences (2014) Vol. 21, Iss. 10, pp. 767-776
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

STAT3 in the systemic inflammation of cancer cachexia
Teresa A. Zimmers, Melissa L. Fishel, Andrea Bonetto
Seminars in Cell and Developmental Biology (2016) Vol. 54, pp. 28-41
Open Access | Times Cited: 200
Tumor-associated macrophages in cancers
Wenwei Hu, Xin Li, C. Zhang, et al.
Clinical & Translational Oncology (2015) Vol. 18, Iss. 3, pp. 251-258
Closed Access | Times Cited: 133
New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma
Sara Massironi, Lorenzo Pilla, Alessandra Elvevi, et al.
Cells (2020) Vol. 9, Iss. 3, pp. 688-688
Open Access | Times Cited: 74
Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness
Simone Brivio, Massimiliano Cadamuro, Mario Strazzabosco, et al.
World Journal of Hepatology (2017) Vol. 9, Iss. 9, pp. 455-455
Open Access | Times Cited: 83
High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation
Charupong Saengboonmee, Wunchana Seubwai, Chawalit Pairojkul, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 78
Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistance
Laura Fouassier, Marco Marzioni, Marta B. Afonso, et al.
Liver International (2019) Vol. 39, Iss. S1, pp. 43-62
Open Access | Times Cited: 64
IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort study
Jung-Ta Kao, Chun-Lung Feng, Cheng-Ju Yu, et al.
BMC Gastroenterology (2015) Vol. 15, Iss. 1
Open Access | Times Cited: 53
Cuproptosis-related genes score and its hub gene GCSH: A novel predictor for cholangiocarcinomas prognosis based on RNA seq and experimental analyses
Rui He, Yihu Li, Pengcheng Jiao, et al.
Journal of Cancer (2024) Vol. 15, Iss. 6, pp. 1551-1567
Open Access | Times Cited: 5
Berberine Induces Cell Cycle Arrest in Cholangiocarcinoma Cell Lines <i>via</i> Inhibition of NF-κB and STAT3 Pathways
Nattapong Puthdee, Wunchana Seubwai, Kulthida Vaeteewoottacharn, et al.
Biological and Pharmaceutical Bulletin (2017) Vol. 40, Iss. 6, pp. 751-757
Open Access | Times Cited: 40
Opisthorchis viverrini Infection Activates the PI3K/AKT/PTEN and Wnt/β-catenin Signaling Pathways in a Cholangiocarcinogenesis Model
Supak Yothaisong, Malinee Thanee, Nisana Namwat, et al.
Asian Pacific Journal of Cancer Prevention (2015) Vol. 15, Iss. 23, pp. 10463-10468
Open Access | Times Cited: 39
Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand
Sunitta Saensa‐Ard, Saman Leuangwattanawanit, Laddawan Senggunprai, et al.
Tumor Biology (2017) Vol. 39, Iss. 11, pp. 101042831772592-101042831772592
Open Access | Times Cited: 39
Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells
Hasaya Dokduang, Puangrat Yongvanit, Nisana Namwat, et al.
Oncology Reports (2016) Vol. 35, Iss. 4, pp. 2065-2072
Open Access | Times Cited: 38
Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT/mTOR and EMT signaling pathways
Rattanaporn Jaidee, Veerapol Kukongviriyapan, Laddawan Senggunprai, et al.
Life Sciences (2022) Vol. 296, pp. 120427-120427
Closed Access | Times Cited: 18
The role of tumour microenvironment: a new vision for cholangiocarcinoma
Ziyan Chen, Pengyi Guo, Xiaozai Xie, et al.
Journal of Cellular and Molecular Medicine (2018) Vol. 23, Iss. 1, pp. 59-69
Open Access | Times Cited: 29
Modulation of STAT3 Signaling, Cell Redox Defenses and Cell Cycle Checkpoints by β-Caryophyllene in Cholangiocarcinoma Cells: Possible Mechanisms Accounting for Doxorubicin Chemosensitization and Chemoprevention
Antonella Di Sotto, Silvia Di Giacomo, Elisabetta Rubini, et al.
Cells (2020) Vol. 9, Iss. 4, pp. 858-858
Open Access | Times Cited: 26
Metformin Inhibits Migration and Invasion of Cholangiocarcinoma Cells
Son Hong Trinh, Huyen Nguyen, Kween Saimuang, et al.
PubMed (2017) Vol. 18, Iss. 2, pp. 473-477
Closed Access | Times Cited: 26
The synergistic antitumor effect of Huaier combined with 5-Florouracil in human cholangiocarcinoma cells
Zhaoyu Fu, Kexin Ma, Bing Dong, et al.
BMC Complementary and Alternative Medicine (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 23
γ-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus
Charupong Saengboonmee, Supannika Sorin, Sakkarn Sangkhamanon, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 28, pp. 4416-4432
Open Access | Times Cited: 7
Cratoxylum formosumExtracts Inhibit Growth and Metastasis of Cholangiocarcinoma Cells by Modulating the NF-κB and STAT3 Pathways
Laddawan Senggunprai, Wachiraporn Thammaniwit, Veerapol Kukongviriyapan, et al.
Nutrition and Cancer (2016) Vol. 68, Iss. 2, pp. 328-341
Closed Access | Times Cited: 21
IL-6-DEPENDENT STAT3 ACTIVATION AND INDUCTION OF PROINFLAMMATORY CYTOKINES IN PRIMARY SCLEROSING CHOLANGITIS
Leona Dold, Leonie Frank, Philipp Lutz, et al.
Clinical and Translational Gastroenterology (2023)
Open Access | Times Cited: 6
Acteoside attenuates TSLP-induced mast cell proliferation via down-regulating MDM2
Myoung-schook Yoou, Hyung‐Min Kim, Hyun‐Ja Jeong
International Immunopharmacology (2015) Vol. 26, Iss. 1, pp. 23-29
Closed Access | Times Cited: 20
STAT3 Inhibitors in Cancer: A Comprehensive Update
Uddalak Bharadwaj, Moses M. Kasembeli, David J. Tweardy
Cancer drug discovery and develogment/Cancer drug discovery and development (2016), pp. 95-161
Closed Access | Times Cited: 19
Targeting SHP-1-STAT3 signaling: A promising therapeutic approach for the treatment of cholangiocarcinoma
Ming-Hung Hu, Li-Ju Chen, Yen‐Lin Chen, et al.
Oncotarget (2017) Vol. 8, Iss. 39, pp. 65077-65089
Open Access | Times Cited: 19
Haem oxygenase 1 expression is associated with prognosis in cholangiocarcinoma patients and with drug sensitivity in xenografted mice
Sarinya Kongpetch, Anucha Puapairoj, Choon Kiat Ong, et al.
Cell Proliferation (2016) Vol. 49, Iss. 1, pp. 90-101
Open Access | Times Cited: 18
Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines – a new strategy for therapy
Manida Suksawat, Anchalee Techasen, Nisana Namwat, et al.
FEBS Open Bio (2018) Vol. 8, Iss. 4, pp. 513-522
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top